Data Golden December 22nd, Haier Biology announced that the company is planning to merge with Shanghai Laisi by issuing A-shares to all shareholders of Shanghai Laisi, and issuing A-shares to raise matching funds. As this transaction is still in the planning stage and there is uncertainty, in order to ensure fair disclosure of information and protect the interests of investors, the company's securities are scheduled to be suspended from trading starting from December 23, 2024, and the suspension is expected to last for no more than 10 trading days.
Lihat Asli
Halaman ini mungkin berisi konten pihak ketiga, yang disediakan untuk tujuan informasi saja (bukan pernyataan/jaminan) dan tidak boleh dianggap sebagai dukungan terhadap pandangannya oleh Gate, atau sebagai nasihat keuangan atau profesional. Lihat Penafian untuk detailnya.
Haier Bio: Merencanakan penggabungan saham dengan Shanghai Lai Shi, saham dihentikan sementara.
Data Golden December 22nd, Haier Biology announced that the company is planning to merge with Shanghai Laisi by issuing A-shares to all shareholders of Shanghai Laisi, and issuing A-shares to raise matching funds. As this transaction is still in the planning stage and there is uncertainty, in order to ensure fair disclosure of information and protect the interests of investors, the company's securities are scheduled to be suspended from trading starting from December 23, 2024, and the suspension is expected to last for no more than 10 trading days.